Adenosine A3 receptor agonist for the treatment of dry eye diseases including Sjogren's syndrome

摘要

A method for treating and/or preventing Sjogren syndrome, comprising administrating to the individual an A3 adenosine receptor agonist (A3RAg). The A3RAg may be administered either topically or orally.